Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The two screenshots show no substantive changes to the study data (title, conditions, eligibility, locations, enrollment, or outcomes), only minor UI/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T12:53:09.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated page to v3.2.0 with a broad government-operating-status notice; removed a specific resource entry (Carcinoma of esophagus) from the Genetic and Rare Diseases Information Center, and retained general references to NIH/C cc and related sites.
    Difference
    3%
    Check dated 2025-10-05T17:28:48.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Update the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.
    Difference
    0.1%
    Check dated 2025-09-28T10:46:11.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Updated core content: Revision updated from v3.0.1 to v3.0.2. Removed 'Back to Top' as a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T00:30:10.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T21:20:26.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as specific medical topics related to esophageal cancer and pembrolizumab. However, many related terms and previous location details have been removed.
    Difference
    2%
    Check dated 2025-08-30T15:47:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.